Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
破解密码：了解Caribou Biosciences分析师评论
During the last three months, 5 analysts shared their evaluations of Caribou Biosciences (NASDAQ:CRBU), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，5位分析师分享了他们对Caribou Biosciences（纳斯达克: CRBU）的评价，展示了从看涨到看跌的不同观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.0, a high estimate of $24.00, and a low estimate of $9.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.64%.
分析师评估的12个月价格目标揭示了更多信息，其中平均目标为19.0美元，最高估值为24.00美元，最低估值为9.00美元。随着分析师将平均价格目标下调13.64％，情绪出现了负面变化。
Analyzing Analyst Ratings: A Detailed Breakdown...
分析分析师评...
登录免费看全文
登录/注册